MICHELE REDELL to Dihydroergotamine
This is a "connection" page, showing publications MICHELE REDELL has written about Dihydroergotamine.
Connection Strength
0.155
-
Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia. Leukemia. 2019 01; 33(1):52-63.
Score: 0.155
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.